Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs Allopurinol in Gout
NCT02082769Phase 3Completed
- Sponsor
- Xijing Hospital
- Start
- Jul 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of febuxostat in gout (3 arms), sponsored by Xijing Hospital. Primary endpoint: Percentage of Subjects Whose Last Three Serum Urate Levels Are <6.0 mg/dL. Started Jul 2011; status: completed.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT02082769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02082769.